Reprieve Cardiovascular, Inc. is developing innovative and groundbreaking therapies that aim to improve the lives of more than 25 million heart failure patients around the world. Reprieve is bringing intelligence to decongestion management to safely accelerate fluid removal for heart failure patients. In 2022, Reprieve initiated the FASTR Trial (pilot study) to compare decongestive therapy administered by the Reprieve Decongestion Management System to Optimal Diuretic Therapy in the treatment of patients diagnosed with acute decompensated heart failure. Reprieve is a privately held medical device company, headquartered in Milford, Massachusetts, USA.
| Website | http://www.reprievecardio.com |
| Employees | 32 (23 on RocketReach) |
| Founded | 2020 |
| Address | 459 Fortune Blvd, Milford, Massachusetts 01757, US |
| Phone | +508 5418800 |
| Technologies |
HTML
,
Nginx
,
Bootstrap
+7 more
(view full list)
|
| Industry | Medical Equipment Manufacturing, Medical Device, Health Care |
| Keywords | Heart Failure Solutions, Heart Failure Treatment, Cardiovascular Disease, Improving Patient Outcomes, Heart Health Improvement, Congestive Heart Failure, Advanced Cardiac Care, Advanced Heart Failure, Innovative Therapies, Circulatory Health, Groundbreaking Technology, Reducing Hospital Readmissions, Medical Device Technology, Patient Care Solutions |
| Competitors | Philips, Boston Scientific, Johnson & Johnson, Edwards Lifesciences, ZOLL Medical Corporation, Medtronic, Abbott, LivaNova, Sorin Group, Terumo Heart, Inc. +42 more (view full list) |
Looking for a particular Reprieve Cardiovascular employee's phone or email?
Reprieve Cardiovascular Questions
Mark Pacyna is the CEO of Reprieve Cardiovascular.
23 people are employed at Reprieve Cardiovascular.
Reprieve Cardiovascular is based in Milford, Massachusetts.
Top Reprieve Cardiovascular Employees
-
Mark Pacyna
Chief Executive Officer at Reprieve Cardiovascular
Minneapolis, MN, US34 -
Tony Fields
Chief Operating Officer at Reprieve Cardiovascular
California, United States23 -
25
-
Andrew Halpert
VP of R and D at Reprieve Cardiovascular
Brookline, MA, US25 -
Rachit Parikh
Director of Regulatory Affairs at Reprieve Cardiovascular
San Diego, CA, US21 -
22
-
Jacob Davis
Director Of Quality at Reprieve Cardiovascular
Providence, RI, US25+ -
Annemarie Forrest
VP of Clinical Affairs at Reprieve Cardiovascular
Ann Arbor, MI, US13
Related Companies
